Pulmonary administration of erythropoietin
AssigneeAmgen Inc.
InventorsColin G. Pitt, Robert M. Platz
Life of this patent
Estimating the term…
Abstract
Erythropoietin (EPO) can be delivered systemically in therapeutically or prophylactically effective amounts by pulmonary administration using a variety of pulmonary delivery devices, including nebulizers, metered dose inhalers and powder inhalers. Aerosol administration of EPO in accordance with this invention results in significant elevation of red blood cell levels. EPO can be administered in this manner to medically treat or prevent anemia, as well as to treat or prevent other maladies related to erythropoiesis.
Claims21
A method comprising pulmonary administration to a mammal of a therapeutically effective amount of erythropoietin in the absence of an absoftion enhancing agent.
Dependencies are inferred from the claim text.